Table 1 Demographics on neuropathology cohorts used

Demographics

Number of cases (M/F)

52 (30/22)

59 (23/36)

23 (12/11)

Average age at death (std. dev.)

70.44 (10.22)

70.83 (14.96)

83.83 (7.32)

Race/ethnicity

Caucasian

42 (80.77%)

48 (81.36%)

18 (78.26%)

Black/African American

10 (19.23%)

7 (11.86%)

1 (4.35%)

Hispanic

–

–

2 (8.70%)

Asian

–

–

1 (4.35%)

Unknown

–

4 (6.78%)

1 (4.35%)

Braak NFT Stage

0

1 (1.92%)

4 (6.78%)

–

I

4 (7.69%)

7 (11.86%)

–

I–II

2 (3.85%)

–

–

II

7 (13.46%)

5 (8.47%)

1 (4.35%)

III

5 (9.62%)

7 (11.86%)

3 (13.04%)

IV

4 (7.69%)

6 (10.17%)

3 (13.04%)

V

7 (13.46%)

4 (6.78%)

5 (21.74%)

VI

22 (42.31%)

26 (44.07%)

11 (47.83%)

Tau antibody (WSI counts)

PHF-1

138 (65.71%)

173 (73.00%)

–

AT8

23 (10.95%)

28 (11.81%)

92 (100%)

CP13

12 (5.71%)

–

–

pan-tau

37 (17.62%)

36 (15.19%)

–